Flavia Borellini
Director/Board Member at REVOLUTION MEDICINES, INC.
Net worth: 323 009 $ as of 2024-03-30
Profile
Flavia Borellini is an Independent Director at Cantargia AB, Revolution Medicines, Inc., and Viracta Therapeutics, Inc. She is also a Director at Kartos Therapeutics, Inc. and a Member of Roche Group.
Previously, she served as the Chief Executive Officer at Acerta Pharma BV from 2016 to 2019, VP-Global Product & Portfolio Strategy at AstraZeneca PLC from 2018 to 2020, and Vice President-Program Leadership at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
Dr. Borellini holds a doctorate degree from Università degli Studi di Modena e Reggio Emilia.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-09-25 | 10,022 ( 0.01% ) | 323 009 $ | 2024-03-30 | |
2023-06-07 | 0 ( -.--% ) | - $ | 2024-03-30 |
Flavia Borellini active positions
Companies | Position | Start |
---|---|---|
REVOLUTION MEDICINES, INC. | Director/Board Member | 2021-06-21 |
VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2021-08-13 |
CANTARGIA AB | Director/Board Member | 2020-09-30 |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Director/Board Member | 2018-01-31 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Former positions of Flavia Borellini
Companies | Position | End |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 2019-12-31 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Chief Executive Officer | 2019-01-31 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2013-09-30 |
Training of Flavia Borellini
Università degli Studi di Modena e Reggio Emilia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
CANTARGIA AB | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
VIRACTA THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
- Stock Market
- Insiders
- Flavia Borellini